Ameritas Advisory Services’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$258K Sell
1,169
-359
-23% -$99.3K 0.01% 1005
2026
Q1
$451K Sell
1,528
-231
-13% -$68.6K 0.02% 610
2025
Q4
$480K Buy
1,759
+1,375
+358% +$374K 0.02% 579
2025
Q3
$104K Sell
384
-127
-25% -$34.6K 0.01% 824
2025
Q2
$141K Buy
+511
New +$139K 0.01% 851
2023
Q2
Sell
-476
Closed -$90.7K 901
2023
Q1
$90.7K Sell
476
-812
-63% -$147K ﹤0.01% 1038
2022
Q4
$217K Buy
+1,288
New +$224K 0.01% 801

Other funds holding CME

Ameritas Advisory Services's CME Position: Q2 2026 in Review

Ameritas Advisory Services reduced its CME Group (CME) stake by 23% in Q2 2026, selling an estimated $99.3K and leaving 1,169 shares worth $258K. The position accounts for 0.01% of the portfolio, ranked #1005.

Ameritas Advisory Services first reported a position in CME in Q4 2022 and has held it in 7 quarters since. The position peaked at $480K in Q4 2025. 1,701 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Ameritas Advisory Services held 1,169 shares of CME Group worth $258K as of Q2 2026.
  • Ameritas Advisory Services sold 359 CME Group shares in Q2 2026, an estimated $99.3K.
  • CME Group made up 0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #1005 holding.
  • Ameritas Advisory Services first reported a position in CME Group in Q4 2022 and has held it in 7 quarters since.
  • Ameritas Advisory Services's CME Group position peaked at $480K in Q4 2025.
  • 1,701 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.